GRFS
Grifols SA ADR
NASDAQ: GRFS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$7.91
-1.98% today
Updated 2026-04-29
Market cap
$5.38B
P/E ratio
11.46
P/S ratio
0.72x
EPS (TTM)
$0.69
Dividend yield
2.22%
52W range
$7 – $11
Volume
0.8M
Grifols SA ADR (GRFS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
5.34%
Operating margin
17.50%
ROE
6.17%
ROA
4.24%
Debt/equity
1.87x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $648.80M | $45.39M | 68.68% | 15.49% | 7.00% |
| 2007 | $703.29M | $87.77M | 74.49% | 20.81% | 12.48% |
| 2008 | $814.31M | $121.73M | 78.43% | 24.92% | 14.95% |
| 2009 | $913.19M | $147.97M | 81.16% | 24.81% | 16.20% |
| 2010 | $990.73M | $115.51M | 77.03% | 21.16% | 11.66% |
| 2011 | $1.80B | $50.31M | 74.01% | 15.53% | 2.80% |
| 2012 | $2.62B | $256.69M | 50.73% | 25.18% | 9.79% |
| 2013 | $2.74B | $345.55M | 51.71% | 26.85% | 12.60% |
| 2014 | $3.36B | $470.25M | 50.64% | 25.56% | 14.01% |
| 2015 | $3.93B | $532.14M | 49.08% | 24.66% | 13.52% |
| 2016 | $4.05B | $545.46M | 47.22% | 23.20% | 13.47% |
| 2017 | $4.32B | $662.70M | 49.84% | 23.24% | 15.35% |
| 2018 | $4.49B | $596.64M | 45.68% | 22.16% | 13.30% |
| 2019 | $5.10B | $625.15M | 45.92% | 22.19% | 12.26% |
| 2020 | $5.34B | $618.55M | 42.23% | 18.65% | 11.58% |
| 2021 | $4.93B | $188.73M | 39.78% | 12.06% | 3.83% |
| 2022 | $6.06B | $185.03M | 36.51% | 12.90% | 3.05% |
| 2023 | $6.59B | $42.32M | 37.67% | 11.87% | 0.64% |
| 2024 | $7.21B | $156.92M | 38.75% | 16.53% | 2.18% |
| 2025 | $7.23B | $386.13M | 35.70% | 16.43% | 5.34% |